Clinical trial G1T48-01
A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Ascending Doses of G1T48 Alone and in Combination with Palbociclib in Women with Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer (G1T48-01)
Cancers | |
---|---|
Organ | Breast |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1 |
Academic trial | Non |
Sponsor | G1 Therapeutics |
EudraCT Identifier | 2017-004502-17 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03455270 |
Inclusion criteria | Any line/ ER positive/ HER2 negative/ RECIST 1.1 |
Last update |